Atara Biotherapeutics (ATRA) Revenue Growth (1y) (2023 - 2026)
Atara Biotherapeutics (ATRA) Revenue Growth (1y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
37.90% |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Atara Biotherapeutics |
137.85 Mn |
129.45 Mn |
392,000.00 |
-99.47% |
| Date | Value |
|---|
| Mar 31, 2026 |
-99.47% |
| Dec 31, 2025 |
-95.13% |
| Sep 30, 2025 |
-91.41% |
| Jun 30, 2025 |
-38.63% |
| Mar 31, 2025 |
258.77% |
| Dec 31, 2024 |
571.72% |
| Sep 30, 2024 |
1,779.79% |
| Jun 30, 2024 |
3,511.60% |
| Mar 31, 2024 |
2,131.40% |
| Dec 31, 2023 |
2,106.33% |
| Jun 30, 2023 |
-98.46% |
| Mar 31, 2023 |
-83.24% |
